Vitamins B2 and B6 and Genetic Polymorphisms Related to One-Carbon Metabolism as Risk Factors for Gastric Adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition

Abstract

B vitamins and polymorphisms in genes coding for enzymes involved in one-carbon metabolism may affect DNA synthesis and methylation and thereby be implicated in carcinogenesis. Previous data on vitamins B2 and B6 and genetic polymorphisms other than those involving MTHFR as risk factors for gastric cancer (GC) are sparse and inconsistent. In this case-control study nested within the European Prospective Investigation into Cancer and Nutrition cohort, cases (n = 235) and controls (n = 601) were matched for study center, age, sex, and time of blood sampling. B2 and B6 species were measured in plasma, and the sum of riboflavin and flavin mononucleotide was used as the main exposure variable for vitamin B2 status, whereas the sum of pyridoxal 5′-phosphate, pyridoxal, and 4-pyridoxic acid was used to define vitamin B6 status. In addition, we determined eight polymorphisms related to one-carbon metabolism. Relative risks for GC risk were calculated with conditional logistic regression, adjusted for Helicobacter pylori infection status and smoking status. Adjusted relative risks per quartile (95% confidence interval, P trend ) were 0.85 (0.72-1.01, 0.06) for vitamin B2 and 0.78 (0.65-0.93, <0.01) for vitamin B6. Both relations were stronger in individuals with severe chronic atrophic gastritis. The polymorphisms were not associated with GC risk and did not modify the observed vitamin-cancer associations. In summary, results from this large European cohort study showed an inverse association between vitamin B2 and GC risk, which is borderline significant, and a significant inverse association between vitamin B6 and GC risk. Cancer Epidemiol Biomarkers Prev; 19(1); 28-38. ©2010 AACR.

High Intake of Folate from Food Sources Is Associated with Reduced Risk of Esophageal Cancer in an Australian Population ,

“…Results from epidemiologic studies investigating the association between riboflavin and risk of cancers have been inconsistent. For instance, whereas inverse associations have been reported for plasma riboflavin and gastric (64) or colorectal adenomas (65,66), a null association was reported between riboflavin and risk of breast cancer in a prospective study (67). It has been suggested that effects of folate deficiency on DNA methylation are gene and site specific, highly complex, and seem to depend on cell type, target organ, stage of transformation, and degree and duration of folate depletion (68).…”

Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)

“…Even if a strength of this study is the measurement of the plasma concentration of fatty acids in a subset of cases from which blood samples were collected before cancer diagnosis, the possibility that prediagnostic SCAG may have affected absorption and metabolism of fatty acids (reverse causation), because it was the case for vitamins B-6 and riboflavin (54), cannot be ruled out, despite the absence of statistical heterogeneity by time since diagnosis and SCAG status. Finally, we cannot exclude results due to chance alone because of the high number of tests performed.…”

Indicators and methods for folate, vitamin B-12, and vitamin B-6 status assessment in humans

“…Both assays show high reproducibility with only 7% between-day variation for PLP. The methods meet optimum imprecision requirements and can be employed in large population-based studies [82,83].…”